Drug Profile
WR 151327
Alternative Names: NSC 327729; NSC 335662Latest Information Update: 15 Oct 2004
Price :
$50
*
At a glance
- Originator Nonindustrial source; Southern Research Institute
- Developer MedImmune Oncology; Nonindustrial source
- Class Antivirals; Radioprotectives
- Mechanism of Action Oxygen radical scavengers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Chemotherapy-induced damage; HIV infections